Toleranzia Overview

  • Founded
  • 2011
Founded
  • Status
  • Public
  • Employees
  • 4
Employees
  • Stock Symbol
  • TOL
Stock Symbol
  • Share Price
  • $0.17
  • (As of Thursday Closing)

Toleranzia General Information

Description

Toleranzia AB is a pharmaceutical company based in Sweden. The company's drug candidate, TOL2, is being developed for the treatment of the autoimmune neuromuscular disease myasthenia gravis, an orphan disease.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
STO
Primary Office
  • Erik Dahlbergsgatan 11A
  • 411 26 Goteborg
  • Sweden
+46 076-319 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Toleranzia Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.17 $0.17 $0.12 - $0.33 $15M 86.2M 579K -$0.01

Toleranzia Financials Summary

In Thousands,
USD
TTM 30-Jun-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 3,080 4,827 6,413 3,130
Revenue 0 0 0 0
EBITDA (663) (531) (797) (648)
Net Income (663) (531) (799) (650)
Total Assets 8,287 8,847 4,134 3,381
Total Debt 0 104 91 95
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Toleranzia Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Toleranzia‘s full profile, request access.

Request a free trial

Toleranzia Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Toleranzia AB is a pharmaceutical company based in Sweden. The company's drug candidate, TOL2, is being developed for th
Drug Discovery
Goteborg, Sweden
4 As of 2021
00.000
0.000 0000-00-00
00000000 00.000

00000 00

t. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pari
000000000000000
Atlanta, GA
000 As of 0000
000.00
000000000000 000.00

0000000

adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad mini
0000 000000000
Cambridge, MA
00 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Toleranzia Competitors (13)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Arbor Pharmaceuticals Private Equity-Backed Atlanta, GA 000 000.00 000000000000 000.00
0000000 0000000000 Formerly VC-backed Cambridge, MA 00 00000 000000000 00000
000000000 Formerly VC-backed South San Francisco, CA 00000 000.00 00000000000
000000 00000000 Formerly VC-backed Foster City, CA 00000 00.000 000000000 00.000
0000000 000 Corporation New York, NY 00 00000 00000000 00000
You’re viewing 5 of 13 competitors. Get the full list »

Toleranzia Executive Team (4)

Name Title Board Seat Contact Info
Charlotte Fribert Chief Executive Officer
Johanna Hultgren Chief Financial Officer
Björn Löwenadler Chief Business Officer
Vidar Wendel-Hansen Chief Medical Officer
To view Toleranzia’s complete executive team members history, request access »

Toleranzia Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Toleranzia Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Toleranzia‘s full profile, request access.

Request a free trial